Previous close | 2.4600 |
Open | 2.7200 |
Bid | 0.8000 |
Ask | 4.1000 |
Strike | 25.00 |
Expiry date | 2024-11-15 |
Day's range | 2.4600 - 2.7200 |
Contract range | N/A |
Volume | |
Open interest | 1.61k |
With its stock down 7.9% over the past month, it is easy to disregard Pacira BioSciences (NASDAQ:PCRX). However, stock...
Jonathan Slonin, Chief Medical Officer of Pacira BioSciences Inc (NASDAQ:PCRX), executed a sale of 5,012 shares of the company on June 11, 2024, as reported in a recent SEC Filing.
TAMPA, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2024 Jefferies Global Healthcare Conference at 11:00 AM ET on Thursday, June 6, 2024 in New York. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event. About Pacira Pacira BioSciences, In